Publications
497 publications
- Date
- Relevance
-
Donepezil hydrochloride (Aspen) for the indication symptomatic treatment of mild to moderately severe Alzheimer’s dementia
The WAR has drawn up a pharmacotherapeutic report for the medicine donepezil (hydrochloride) Aspen film-coated tablets. Its ...
-
Ruxolitinib (Jakavi) for the indication symptomatic treatment of myelofibrosis
Ruxolitinib has an added value in comparison with placebo or BAT in the treatment of the disease-related splenomegaly or symptoms ...
-
Ulipristal (Esmya) for preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age
The applicant claims that treatment with ulipristal is a cost-effective intervention for the preoperative treatment of moderate ...
-
Ivabradine (Procoralan) for the indication chronic heart failure
Ivabradine has an added therapeutic value in comparison with placebo in patients with chronic heart failure HYHA class II-IV in ...
-
Apixaban (Eliquis) for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
For the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one of more risk ...
-
Fidaxomycin (Dificlir) for the indication Clostridium difficile-related disease
In the treatment of patients with CDAD who are severely ill or who have been admitted to hospital, the therapeutic value of ...
-
Endoluminal fundoplication with EsophyX incases of gastro-oesophageal reflux
There is insufficient evidence of a good methodological quality to be able to conclude that endoluminal fundoplication with ...
-
Treating severe asymptomatic A. carotid stenosis in combination with an indicated bypass operation or heart valve surgery
CVZ’s reply to this question is negative: the above-mentioned treatment does not fulfil the established medical science and ...
-
Endobronchial lung volume reduction by means of one-way valves in cases of emphysema
In this outcome CVZ assessed whether using one-way valves to reduce endobronchial lung volume (BLVR) in cases of emphysema can be ...
-
Fampridine (Fampyra) for the indication ‘improvement in MS patients’ walking ability
The therapeutic value of fampridine is the same as that of pharmacy-compounded fampridine (=4-AP) in improving the walking ...